Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia

Use of MEOPA for Elderly With Dementia.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00822224

Enrollment

Registered

2009-01-14

Start date

2009-01-31

Completion date

2011-12-31

Last updated

2011-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

acute pain, MEOPA, Dementia

Brief summary

Acute pain is frequent in elderly especially in geriatrics acute care units where painful procedures are often occurring. MEOPA represents an alternative to opioïd therapy to prevent procedural pain during the treatment of pressure ulcers. In this study, cognitive impairment and dementia do not limit the use of MEOPA. The new approach in the management of acute procedural pain provides effective and safe analgesia in frail old patients.

Interventions

DRUGMEOPA

inhalation of MEOPA during the painful care

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

75 Years to No maximum

Healthy volunteers

Inclusion criteria

* dementia (Folstein scoring between 0 and 25) * older than 75 * health necessitating of painful care for example eschar care

Exclusion criteria

* bullous emphysema * pneumothorax

Design outcomes

Primary

Measure	Time frame
feasibility of use of MEOPA as tolerance to mask, MEOPA inhalation	one time, at the first care with MEOPA

Secondary

Measure	Time frame
satisfaction rate of patient	one time, at the first care with MEOPA

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026